LensGen, Inc

08/23/2023

https://t.co/xf7GPBwaE0

Ocular Surgery News | Healio | OSN focuses on a topic dear to my heart, premium IOLs.In 2013, Malvina B. Eydelman, MD, director of the FDA’s Division of Ophthalmic and Ear, Nose and Throat Devices, chaired an expert panel titled “Developing Novel Endpoints for Premium Intraocular Lenses....

08/22/2023

https://www.healio.com/news/ophthalmology/20230814/future-of-iols-modular-shapechanging-multifunctional

Ocular Surgery News | Replicating the physiological mechanism of focusing of the crystalline lens with an IOL has been the long-time ultimate goal of presbyopia management.Several attempts seemed successful at first but eventually failed because fibrosis occurred with time, reducing the ability of t...

08/17/2023

LensGen’s participation in TiE Young Entrepreneurs (TYE) OC 2023 Summer Shadow Day Program was a huge success!

TIE Global

06/12/2023

Sumit Garg, M.D. Presented Thirty-Six Months Grail Study Visual Outcomes at the American Society of Cataract and Refractive Surgery Conference

San Diego, Calif., May 6, 2023 – Sumit Garg, M.D., Vice Chair of Clinical Ophthalmology & Medical Director at the Gavin Herbert Eye Institute, University of California, Irvine presented the long-term (36 months) visual outcomes during scientific sessions on Presbyopia Correcting IOLs. Providing bo...

11/17/2022

Ramgopal Rao, CEO, LensGen, Inc. is presenting at BTIG’s Ophthalmology Day 2022, on Tuesday, November 29, 2022. This conference is being hosted by BTIG, a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. BTIG’s Corporate Access program hosts client events across the consumer, digital assets, energy and infrastructure, financials, healthcare, real estate and technology sectors. To join the conference, email [email protected].

10/11/2022

https://l.facebook.com/l.php?u=https%3A%2F%2Fmy.mtr.cool%2Fugahakshbw%3Ffbclid%3DIwAR0HWhzZTzNnfTKdKld0JHmiZdTKCEM0kwSwU61HhRK2v9k46SzP2_UExRk&h=AT22KkHkF0TzmBHLFqRABeFqx6mGwMwf5q01IjxZasZiXDBG1tXKSZrZD_kJasuS9Tl4YMS2iqq3GibveabmcnX4HeZGeDsl1epfW_SLXqa06XNR6LzePE7143Dt1JtavHWy&__tn__=-UK-R&c[0]=AT1TnxQci8VrEFMRUbSXJMg_1WsCPHyYvXAFIDDkBrWcL_H0giumtMcpVK5mSmJPMNTVStPjHCgQoy9u2wv1TAZHmyb_E6TDBkD4pqitfOq-2C5KaNOMiQ4rP2WX1WePOeEVuHCHzRUDCtvTpl_0hFYzvSPThQj6kJhy93YuQMJ7NipiP74OmGzq3sR39hYENwbWXz7K39be

An abstract is unavailable.

10/11/2022

https://eyetube.net/meeting-coverage/aao-2022/a-look-at-a-new-shape-changing-iol

Eric D. Donnenfeld, MD, shares the long-term refractive and contrast sensitivity outcomes of a clinical trial in Mexico evaluating a novel accommodating, shape-changing IOL.

05/26/2022

LensGen is excited to support and attend 's Ophthalmology Tech Summit on June 16 and 17 at the Balboa Bay Resort in Newport Beach! To register and learn more: https://octaneoc.org/ophthalmology-tech-summit/

11/29/2021

https://www.prnewswire.com/news-releases/lensgen-receives-ide-approval-from-the-us-fda-to-begin-clinical-study-of-the-juvene-presbyopia-correcting-intraocular-lens-301432541.html?=prn

08/17/2021

LensGen's Panel Discussion at ASCRS 2021 – Las Vegas

Closing in on the “Holy Grail”

How Juvene will Shape the Future

08/03/2021

Eric Donnenfeld, MD wins best paper, Presbyopia Correcting IOLs: New Technology session at American Society of Cataract & Refractive Surgery

Paper Title: Twelve Months Grail Study Results after Implantation of a New Modular, Shape-Changing, Fluid-Optic Intraocular Lens

https://www.ophthalmologytimes.com/view/study-shows-refractive-stability-of-fluid-optic-iol

Eric Donnenfeld, MD, presents results of the year-long Grail Study demonstrating the safety and performance of the Juvene IOL from LensGen Inc.

07/19/2021

https://www.healio.com/news/ophthalmology/20210712/video-enhanced-depth-of-focus-among-upcoming-iol-innovations

NEWPORT BEACH, Calif. — In this video from the Octane Ophthalmology Technology Summit, Uday Devgan, MD, discusses upcoming technological innovations such as the LensGen Juvene IOL.